British Drugmaker Funds Research On Chronic Disease In Africa

One of the world's largest drugmakers says it will invest more than $200 million in Africa over the next five years in a push for better treatment of noncommunicable diseases there.

GlaxoSmithKline said the funding would be focused on sub-Saharan Africa, where the company already employs about 1,500 people and operates three factories. The money would go toward building five more factories and funding of research and development focused on the region.

A centerpiece of the...